PEG MGF 2 mg

PEG MGF 2 mg — mechano growth factor, engineered to last
Native MGF is gone within minutes. Attaching polyethylene glycol changes that entirely, and that single modification is what turned a fleeting splice variant into a usable research compound.

What is PEG MGF?

Mechano Growth Factor is a splice variant of IGF-1 expressed in muscle tissue in response to mechanical loading and damage, distinguished by a unique C-terminal peptide sequence. Its defining problem as a research tool was extreme instability — native MGF is cleared from circulation very rapidly. PEGylation, the covalent attachment of a polyethylene glycol chain, shields the molecule from enzymatic degradation and renal clearance, extending its functional half-life dramatically. PEG MGF is therefore studied as a stabilised form of a signal that, in nature, is deliberately transient.

Research interest

• Muscle satellite cell biology — investigated in research examining satellite cell activation and proliferation following mechanical stress.
• Splice variant signalling — studied for how the MGF C-terminal sequence signals differently from systemic IGF-1.
• Tissue regeneration models — of interest to researchers exploring repair and remodelling in preclinical musculoskeletal systems.
• PEGylation chemistry — a widely cited case study in half-life extension through polymer conjugation.
• Local versus systemic growth signalling — referenced in literature distinguishing autocrine and paracrine growth factor activity from endocrine IGF-1.

PEGylated Proteins carry additional handling considerations: the polymer conjugate affects solubility behaviour and makes the material particularly intolerant of aggressive agitation. Verified conjugation quality and batch traceability are essential to reproducible results.

Specifications

• Content: 2 mg of active substance per vial
• Form: PEGylated lyophilised peptide (vial)
• Purity: Pharmaceutical-grade, batch-tested and lot-traceable
• Presentation: Sealed, tamper-evident single vial
• Storage: -20 °C sealed; 2-8 °C short-term

Handling & storage

Store sealed lyophilised vials at -20 °C for long-term stability; short periods at 2-8 °C are generally tolerated during transit and handling. Keep vials sealed, protected from light and away from moisture and repeated temperature swings. Store sealed and frozen; allow to reach room temperature before opening. Reconstitute gently by directing diluent down the vial wall and swirling rather than shaking, following the laboratory's validated method. PEGylated material should be aliquoted and kept refrigerated, with freeze-thaw cycling kept to an absolute minimum.

Why source it here

• Purity you can document — batch-tested material with traceable lot identification.
• Direct European supply — authentic, sealed vials handled to a strict cold-chain-aware standard.
• No compromise on consistency — controlled sourcing keeps material comparable between orders.
• Rapid discreet dispatch — tracked EU shipping in plain packaging.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only. No statement on this page is a medical claim, and no administration, dosing or protocol guidance is offered or implied.

Related: Peptides · Cagrilintide + Semaglutide 5 mg + 5 mg · Epithalon 50 mg